Showing results (101-110 of 516) with videos related to
Sort By:
Pageof 52
Cranio : the Journal of Craniomandibular Practice|May 19, 2007
Evaluation of the posterior airway space following Biobloc therapy: geometric morphometricsG Dave Singh, Ana Victoria Garcia-Motta, William M HangInternational Journal of Chronic Obstructive Pulmonary Disease|July 20, 2018
Feasibility and challenges of using multiple breath washout in COPDAlan S Bell, Philip J Lawrence, Dave Singh, et al.The European Respiratory Journal|October 13, 2012
Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungsKate Gaffey, Sophie Reynolds, Jonathan Plumb, et al.Clinical & Translational Immunology|October 3, 2022
Increased mast cell activation in eosinophilic chronic obstructive pulmonary diseaseAndrew Higham, Josiah Dungwa, Tuyet-Hang Pham, et al.Therapeutic Advances in Respiratory Disease|May 18, 2019
Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence baseAnthony D D'Urzo, Dave Singh, James F Donohue, et al.Respiratory Research|July 10, 2019
Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspectiveDave Singh, Anthony D D'Urzo, James F Donohue, et al.International Journal of Chronic Obstructive Pulmonary Disease|April 5, 2018
The effect of electronic cigarette and tobacco smoke exposure on COPD bronchial epithelial cell inflammatory responsesAndrew Higham, Declan Bostock, George Booth, et al.Journal of Clinical Pharmacology|November 3, 2009
A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patientsDave Singh, Lucy Smyth, Zoe Borrill, et al.Ugeskrift for Laeger|December 9, 2025
[Christmas article: Flaming heart syndrome: Shared false memories in Danish popular culture]Dave Singh Dhanda, Thomas Kirkeskov Olsson, Lars Hageman Pinborg, et al.BMC Pulmonary Medicine|August 20, 2015
Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trialDave Singh, Sally Worsley, Chang-Qing Zhu, et al.Pageof 52